Can radiotherapy treat SCC effectively? 

Radiotherapy is a highly effective clinical treatment for squamous cell carcinoma and is frequently used within the National Health Service as both a primary cure and a supportive measure after surgery. By using precisely targeted high-energy X-rays, radiotherapy destroys the DNA of cancer cells while allowing the surrounding healthy tissue to recover. In the United Kingdom, this non-surgical approach is particularly valued for its ability to treat tumours in sensitive areas where an operation might be difficult or lead to a less desirable cosmetic outcome. While surgery is often the first choice for many skin cancers, radiotherapy offers a robust and successful alternative that provides high rates of local control and long-term safety for patients. 

What We’ll Discuss in This Article 

• The clinical effectiveness and cure rates of radiotherapy for SCC 

• When radiotherapy is preferred over surgical intervention 

• The role of adjuvant radiotherapy in reducing recurrence 

• Typical treatment schedules and what to expect during sessions 

• Common side effects and the long-term healing process 

• How radiotherapy is used for advanced or metastatic disease 

Clinical effectiveness and cure rates 

Radiotherapy is recognised as a curative treatment modality for squamous cell carcinoma, with success rates that are often comparable to surgical excision for appropriately selected cases. In the United Kingdom, clinical data suggests that radiotherapy achieves high rates of local control, particularly for primary tumours that have not yet spread. For many patients, especially those with smaller lesions, the probability of a complete cure through radiation alone is excellent. 

The effectiveness of the treatment depends on several factors, including the size and location of the tumour, as well as the specific dose and number of sessions prescribed by the clinical oncologist. While surgery allows for immediate laboratory verification of clear margins, modern radiotherapy techniques ensure that the radiation beam covers the entire area of concern, including a safety margin of seemingly healthy skin. This comprehensive coverage is why radiotherapy remains a cornerstone of skin cancer management, providing a reliable pathway to recovery for thousands of patients across the NHS each year. 

When radiotherapy is preferred over surgery 

There are several clinical scenarios where a specialist may recommend radiotherapy as the primary treatment instead of surgery. One of the most common reasons is the location of the tumour on the face, such as on the nose, ears, or eyelids. In these areas, performing a wide surgical excision might require complex reconstruction or could interfere with vital functions like blinking or breathing. Radiotherapy can often destroy the cancer while preserving the natural shape and function of these delicate features. 

Radiotherapy is also a vital option for: 

• Patients who are not fit for a general anaesthetic or prolonged surgery due to other health conditions 

• Large or deep tumours where an operation would be particularly extensive or disfiguring 

• Individuals who prefer a non-invasive approach over a surgical procedure 

• Older patients where a slower, more gradual treatment process may be better tolerated 

The National Health Service explains that radiotherapy may be recommended if the cancer covers a large area or if the location makes surgery difficult. By matching the treatment to the patient’s specific needs, the medical team can achieve the best possible balance between curing the cancer and maintaining the patient’s quality of life. 

The role of adjuvant radiotherapy 

In many cases, radiotherapy is used as an additional treatment after a squamous cell carcinoma has been surgically removed. This is known as adjuvant or post-operative radiotherapy. The primary goal of this approach is to destroy any microscopic cancer cells that might have been left behind at the edges of the surgical site, thereby reducing the risk of the cancer returning in the same spot. 

This is particularly important for high-risk tumours that show certain features in the pathology report, such as: 

• Cancer cells found very close to or at the edge of the removed skin (close or positive margins) 

• Evidence of the cancer growing along the paths of local nerves (perineural invasion) 

• Tumours that are very thick or have grown deep into the subcutaneous fat 

• Aggressive cell types that are more likely to behave unpredictably 

NICE clinical guidelines suggest considering post-operative radiotherapy for squamous cell carcinoma with high-risk features to improve local control and disease-free survival. While surgery provides the initial clearance, the addition of radiotherapy acts as a vital safety net, ensuring the most thorough possible treatment for complex or aggressive cancers. 

What to expect during radiotherapy treatment 

A course of radiotherapy is highly personalised and begins with a planning session at the hospital. During this appointment, the clinical oncologist and radiographers mark the exact area to be treated and may take measurements or photographs. For some treatments on the head or neck, a lightweight plastic mask may be made to help the patient stay in the exact same position for every session. The treatment itself is delivered as an outpatient procedure, meaning patients do not need to stay in the hospital overnight. 

The radiation is usually delivered in daily sessions from Monday to Friday, with a rest over the weekend. A typical course can last anywhere from a single session for very small, low-risk spots to four or six weeks for larger or more complex areas. Each session only takes a few minutes and is completely painless; most patients describe it as being similar to having a standard X-ray. Throughout the course, the patient remains awake and can communicate with the radiographers via an intercom, ensuring they feel supported and comfortable at all times. 

Side effects and the healing process 

Because radiotherapy is a localised treatment, the side effects are usually confined to the area of skin being treated. During the first few weeks, the skin often becomes red, sore, and itchy, similar to the sensation of a significant sunburn. As the treatment progresses, the area may become scaly or develop a scab. These reactions are a normal sign that the radiation is working to destroy the cancer cells and that the healthy cells are beginning their repair process. 

Following the completion of the course, the skin will gradually heal over a period of several weeks or months. It is common for the treated area to appear slightly paler than the surrounding skin or to develop small, spider-like blood vessels (telangiectasia) over the long term. Permanent hair loss may also occur, but only within the specific area that received the radiation. The clinical team provides detailed advice on how to care for the skin during this time, usually recommending gentle washing and the use of specific moisturisers to support the healing process. 

Treatment for advanced and metastatic SCC 

For squamous cell carcinoma that has spread beyond the original site to the nearby lymph nodes or other parts of the body, radiotherapy remains a critical part of the treatment plan. When the lymph nodes are involved, radiotherapy is often used after a surgical neck dissection to ensure all cancer cells in the regional area are addressed. It can also be used as a primary treatment for nodes if surgery is not the best option for the patient. 

In cases where the cancer is very advanced or has reached distant organs, radiotherapy can be used palliatively. This means the goal of the treatment is to shrink the tumour and relieve symptoms such as pain or bleeding, rather than to achieve a total cure. This targeted approach can significantly improve a patient’s comfort and quality of life. Modern radiotherapy, often used in combination with systemic treatments like immunotherapy, ensures that even patients with advanced squamous cell carcinoma have access to effective and compassionate clinical care. 

Conclusion 

Radiotherapy is a highly effective and versatile treatment for squamous cell carcinoma in the UK, offering high cure rates both as a primary therapy and as a follow-up to surgery. It is especially useful for tumours in sensitive facial areas and for patients who are not suitable for an operation. By destroying cancer cells with targeted radiation, it provides a safe and successful pathway for managing both localised and advanced skin cancer. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot (E-E-A-T) 

This article is designed to provide clear and factual information regarding skin health for the general public. The content is written by the Medical Content Team and has been reviewed by Dr. Stefan Petrov. He is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.